Co-Diagnostics, Inc. Accrued Professional Fees, Current
Co-Diagnostics, Inc. (CODX) had Accrued Professional Fees, Current of $146.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedProfessionalFeesCurrent · last filed 2026-03-31
- 2025-12-31: Accrued Professional Fees, Current $146.00K.
- 2024-12-31: Accrued Professional Fees, Current $1.67M.
- 2023-12-31: Accrued Professional Fees, Current $503.89K.
| Period end | Accrued Professional Fees, Current |
|---|---|
| 2025-12-31 | $146.00K 10-K · filed 2026-03-31 |
| 2024-12-31 | $1.67M 10-K · filed 2026-03-31 |
| 2023-12-31 | $503.89K 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |